Kim et al. [352] demonstrated that FGF21 deficiency exacerbated obesity-induced inflammation and atrophic responses in skeletal muscle of obese mice, and FGF21 treatment protected against inflammation-induced atrophy via the AMPK pathway. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.